Product Information
ROSUVASTATIN CALCIUM 40 MG TAB is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0692 per EA under NDC 67877044230. Its NADAC has been published 486 times since Jun 14, 2017.
FDA first approved this application on Mar 21, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877044230
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ROSUVASTATIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206465FDA Approved
3/21/2017
TE Code
AB
On Market Since
3/21/2017
Pharmacological Classes
Price Statistics
The NADAC for ROSUVASTATIN CALCIUM 40 MG TAB has been published 486 times since Jun 14, 2017, and over the history we have for it it has declined 64.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0692 per EA |
|---|---|
| All-time high | $0.1944 (Jun 14, 2017) |
| All-time low | $0.0591 (Apr 22, 2026) |
| 52-week high | $0.0742 |
| 52-week low | $0.0591 |
| Median price | $0.1286 |
| Average price | $0.1230 |
| Largest weekly change | +25.6% (Aug 21, 2024) |
| Weeks tracked | 486 |
| Tracking since | Jun 14, 2017 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Rosuvastatin Calcium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ROSUVASTATIN CALCIUM 40 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ROSUVASTATIN CALCIUM 40 MG TAB, manufactured by Ascend Laboratories, LLC, is $0.0692 per EA (NDC 67877044230), effective Sep 30, 2026.
How has the price of ROSUVASTATIN CALCIUM 40 MG TAB changed over time?
Over the history we have for it, the NADAC for ROSUVASTATIN CALCIUM 40 MG TAB has declined 64.4%. It has been tracked across 486 weekly CMS publications since Jun 14, 2017.
What are the highest and lowest recorded NADAC prices for ROSUVASTATIN CALCIUM 40 MG TAB?
Since Jun 14, 2017, the NADAC for ROSUVASTATIN CALCIUM 40 MG TAB has ranged from a low of $0.0591 (Apr 22, 2026) to a high of $0.1944 (Jun 14, 2017), with a median of $0.1286 per EA.
Are there cheaper alternatives to ROSUVASTATIN CALCIUM 40 MG TAB?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ROSUVASTATIN CALCIUM 40 MG TAB, is $0.0624 per EA — about 10% below ROSUVASTATIN CALCIUM 40 MG TAB.
Who manufactures ROSUVASTATIN CALCIUM 40 MG TAB?
ROSUVASTATIN CALCIUM 40 MG TAB (NDC 67877044230) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.